MARINUS PHARMACEUTICALS INC's ticker is and the CUSIP is 56854Q200. A total of 90 filers reported holding MARINUS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,115,104 | -44.5% | 511,193 | -25.1% | 0.01% | -50.0% |
Q2 2023 | $7,411,852 | +57.4% | 682,491 | 0.0% | 0.03% | +52.9% |
Q1 2023 | $4,709,188 | +262836.2% | 682,491 | +51.7% | 0.02% | +183.3% |
Q4 2022 | $1,791 | -99.9% | 449,948 | -14.8% | 0.01% | -53.8% |
Q3 2022 | $3,511,000 | +577.8% | 527,925 | +392.8% | 0.01% | +550.0% |
Q2 2022 | $518,000 | -48.4% | 107,123 | +26.9% | 0.00% | -33.3% |
Q4 2021 | $1,003,000 | -4.3% | 84,402 | -8.4% | 0.00% | 0.0% |
Q3 2021 | $1,048,000 | -36.6% | 92,101 | 0.0% | 0.00% | -50.0% |
Q2 2021 | $1,652,000 | +15.8% | 92,101 | 0.0% | 0.01% | 0.0% |
Q1 2021 | $1,426,000 | +26.9% | 92,101 | 0.0% | 0.01% | +20.0% |
Q4 2020 | $1,124,000 | -5.0% | 92,101 | 0.0% | 0.01% | -28.6% |
Q3 2020 | $1,183,000 | – | 92,101 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lion Point Capital, LP | 3,629,622 | $33,936,000 | 7.88% |
VR Adviser, LLC | 3,156,803 | $29,516,000 | 4.78% |
Bleichroeder LP | 1,322,463 | $12,365,000 | 2.19% |
Bain Capital Life Sciences Investors, LLC | 1,431,058 | $13,380,000 | 1.30% |
683 Capital Management, LLC | 1,932,829 | $18,072,000 | 0.97% |
Granite Point Capital Management, L.P. | 472,056 | $4,414,000 | 0.92% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,766,000 | $25,862,000 | 0.79% |
Avoro Capital Advisors LLC | 3,150,000 | $29,453,000 | 0.54% |
Artal Group S.A. | 1,000,000 | $9,350,000 | 0.39% |
Stonepine Capital Management, LLC | 56,747 | $531,000 | 0.22% |